
Quarterly ResultAug 10, 2026, 07:35 AM
Surgery Partners Q2 Revenue $848.9M; Reaffirms FY26 Guidance
AI Summary
Surgery Partners, Inc. announced its second quarter 2026 results, reporting a 2.7% increase in revenue to $848.9 million and a 5.0% rise in same-facility revenues. Despite this growth, the company posted a net loss of $15.0 million and a slight decrease in Adjusted EBITDA to $125.2 million compared to the prior year. Management reaffirmed its full-year 2026 revenue guidance of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million, highlighting disciplined execution and portfolio optimization efforts, including a pending divestiture.
Key Highlights
- Q2 2026 Revenue increased 2.7% to $848.9 million.
- Same-facility revenues grew 5.0% and same-facility cases increased 0.3% in Q2.
- Net loss attributable to Surgery Partners, Inc. was $15.0 million for Q2 2026.
- Adjusted EBITDA for Q2 2026 was $125.2 million, down from $129.0 million YoY.
- Reaffirmed full-year 2026 revenue guidance of $3.35 billion to $3.45 billion.
- Reaffirmed full-year 2026 Adjusted EBITDA guidance of at least $530 million.
- Pending divestiture of Idaho Falls facilities is a key step in portfolio optimization.
- Cash and cash equivalents stood at $216.7 million as of June 30, 2026.
Price Impact
More from SGRY